{
  "ticker": "CRL",
  "year": 2024,
  "quarter": 1,
  "last_updated": "2025-04-19T08:01:13.559986",
  "count": 103,
  "transactions": [
    {
      "id": 6603,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 17533,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 31243,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 48955,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 69221,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 6609,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 17539,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 31249,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 48965,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 69231,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 6610,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 6612,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 17540,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 17542,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 31251,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 31258,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 48968,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 48979,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 69234,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 69245,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 6615,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 17545,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 31268,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 48993,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 69259,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 663,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 6600,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 17530,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 31240,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 48946,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 69212,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 666,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 667,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 672,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 6604,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 6605,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 6613,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 17534,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 17535,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 17543,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 31244,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 31245,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 31259,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 48956,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 48960,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 48982,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 69222,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 69226,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 69248,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 668,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 6606,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 17536,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 31246,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 48961,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 69227,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 661,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 662,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 664,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 665,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 669,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 670,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 671,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 673,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 6598,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 6599,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 6601,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 6602,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 6607,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 6608,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 6611,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 6614,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 17528,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 17529,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 17531,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 17532,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 17537,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 17538,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 17541,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 17544,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 31238,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 31239,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 31241,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 31242,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 31247,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 31248,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 31252,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 31266,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 48943,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 48944,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 48948,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 48952,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 48963,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 48964,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 48969,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 48991,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 69209,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 69210,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 69214,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 69218,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 69229,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 69230,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 69235,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 69257,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    }
  ]
}